rolipram and h 89
rolipram has been researched along with h 89 in 29 studies
Research
Studies (29)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (20.69) | 18.2507 |
2000's | 16 (55.17) | 29.6817 |
2010's | 6 (20.69) | 24.3611 |
2020's | 1 (3.45) | 2.80 |
Authors
Authors | Studies |
---|---|
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Katagiri, Y; Miyata, H; Mizutani, T; Nakamura, M; Nakamura, Y; Nakashima, S; Nozawa, Y; Takemura, SO | 1 |
Wise, H | 2 |
Eckly-Michel, A; Lugnier, C; Martin, V | 1 |
Khan, M; Pahan, K; Singh, I | 1 |
Cunha, FQ; Ferreira, SH; Teixeira, MM | 1 |
Cueff, A; Lacoste, A; Malham, SK; Poulet, SA | 1 |
Botana, LM; de la Rosa, LA; Vieytes, MR; Vilariño, N | 1 |
Barnes, PJ; Bergmann, M; Giembycz, MA; Houslay, MD; McPhee, I; Newton, R; Staples, KJ; Tomita, K | 1 |
Abella, C; Hernandez, J; Vargas, ML | 1 |
Higashima, M; Koshino, Y; Ohno, K | 1 |
Baillie, GS; Gall, I; Houslay, MD; Lefkowitz, RJ; McPhee, I; Perry, SJ; Sood, A | 1 |
Bartlick, B; Bartsch, O; Ivell, R | 1 |
Barnes, PJ; Cambridge, LM; Catley, MC; Giembycz, MA; Lum, H; Meja, KK; Newton, R | 1 |
Irifune, M; Nishikawa, T; Ohnishi, Y; Sato, T; Tanaka, K; Teramoto, T | 1 |
Fresno, M; Iñiguez, MA; Jimenez, JL; Muñoz-Fernández, MA | 1 |
Kyoi, T; Noda, K; Oka, M; Ukai, Y | 1 |
Conti, M; Hassell, KA; Karpen, JW; Le, X; Mehats, C; Piggott, LA; Rich, TC; Xin, W | 1 |
Fatma, S; Grunstein, JS; Grunstein, MM; Hu, A; Nino, G | 1 |
Baillie, GS; Furman, BL; Gribble, FM; Houslay, MD; Lynch, MJ; Ong, WK; Pyne, NJ; Reimann, F | 1 |
Cureton, EL; Curran, B; Dozier, KC; Kwan, RO; Sadjadi, J; Victorino, GP | 1 |
Avni, D; Meijler, MM; Philosoph, A; Zor, T | 1 |
Allen, KT; Bonanno, JA; Li, S | 1 |
Kim, HM; Lee, GH; Lee, JW; Lee, MS; Moon, EY | 1 |
Inokuchi, J; Itsumi, M; Kashiwagi, E; Naito, S; Shiota, M; Uchiumi, T; Yokomizo, A | 1 |
Alfonso, A; Botana, LM; Fernández-Araujo, A; Tobío, A | 1 |
Fisher, MJ; Liu, S; Paganini-Hill, A; Yang, F; Yu, C | 1 |
Other Studies
29 other study(ies) available for rolipram and h 89
Article | Year |
---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Effects of selective phosphodiesterase type IV inhibitor, rolipram, on signal transducing phospholipases in neutrophil: inhibition of phospholipases A2, D but not C.
Topics: Animals; Arachidonic Acid; Enzyme Inhibitors; In Vitro Techniques; Inositol Phosphates; Isoquinolines; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phosphodiesterase Inhibitors; Phospholipase D; Phospholipases; Phospholipases A; Protein Kinase Inhibitors; Pyrrolidinones; Rats; Rats, Wistar; Rolipram; Signal Transduction; Sulfonamides; Type C Phospholipases | 1995 |
The inhibitory effect of prostaglandin E2 on rat neutrophil aggregation.
Topics: Adenine; Androstadienes; Animals; Ascitic Fluid; Cell Aggregation; Cells, Cultured; Chemotaxis, Leukocyte; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dinoprostone; Enzyme Inhibitors; Glyburide; Isoquinolines; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phosphatidylinositol 3-Kinases; Phosphodiesterase Inhibitors; Phosphotransferases (Alcohol Group Acceptor); Potassium Channels; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Rolipram; Sulfonamides; Wortmannin | 1996 |
Involvement of cyclic nucleotide-dependent protein kinases in cyclic AMP-mediated vasorelaxation.
Topics: Adenosine Triphosphate; Adrenergic beta-Agonists; Animals; Aorta; Calcium; Cardiotonic Agents; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Endothelium, Vascular; Enzyme Inhibitors; In Vitro Techniques; Isoproterenol; Isoquinolines; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Phosphodiesterase Inhibitors; Pyrazines; Pyrrolidinones; Rats; Rats, Wistar; Rolipram; Signal Transduction; Sulfonamides; Thionucleotides | 1997 |
The effect of prostacyclin mimetics on neutrophil function.
Topics: Acetates; Animals; Cell Aggregation; Cyclic AMP; Epoprostenol; Iloprost; Imidazoles; Isoquinolines; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oxazoles; Peritoneal Cavity; Phenoxyacetates; Pyrrolidinones; Rats; Rolipram; Second Messenger Systems; Sulfonamides | 1997 |
Therapy for X-adrenoleukodystrophy: normalization of very long chain fatty acids and inhibition of induction of cytokines by cAMP.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adrenoleukodystrophy; Animals; Astrocytes; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cytokines; Enzyme Inhibitors; Fatty Acids; Genetic Linkage; Interleukin-1; Isoquinolines; Neuroglia; Oxidation-Reduction; Protein Kinase Inhibitors; Pyrrolidinones; Rats; Rolipram; Sulfonamides; Tumor Necrosis Factor-alpha; X Chromosome | 1998 |
Pharmacological modulation of secondary mediator systems--cyclic AMP and cyclic GMP--on inflammatory hyperalgesia.
Topics: Animals; Bradykinin; Carrageenan; Cyclic AMP; Cyclic GMP; Dinoprostone; Dopamine; Hyperalgesia; Inflammation; Interleukin-1; Interleukin-6; Interleukin-8; Isoquinolines; Male; Oxadiazoles; Phosphodiesterase Inhibitors; Pyrrolidinones; Quinoxalines; Rats; Rats, Wistar; Rolipram; Second Messenger Systems; Sulfonamides; Tumor Necrosis Factor-alpha | 1999 |
Noradrenaline modulates oyster hemocyte phagocytosis via a beta-adrenergic receptor-cAMP signaling pathway.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Flow Cytometry; Hemocytes; Isoproterenol; Isoquinolines; Microscopy, Confocal; Naphthalenes; Norepinephrine; Ostreidae; Phagocytosis; Phenylephrine; Phosphodiesterase Inhibitors; Prazosin; Propranolol; Protein Kinase C; Receptors, Adrenergic, beta; Rolipram; Signal Transduction; Sulfonamides | 2001 |
Modulation of thapsigargin-induced calcium mobilisation by cyclic AMP-elevating agents in human lymphocytes is insensitive to the action of the protein kinase A inhibitor H-89.
Topics: Adenosine Triphosphatases; Bucladesine; Calcium; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cytosol; Enzyme Inhibitors; Fluorescent Dyes; Fura-2; Humans; Isoquinolines; Lymphocytes; Microscopy, Fluorescence; Milrinone; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Rolipram; Sulfonamides; Thapsigargin; Time Factors | 2001 |
Adenosine 3',5'-cyclic monophosphate (cAMP)-dependent inhibition of IL-5 from human T lymphocytes is not mediated by the cAMP-dependent protein kinase A.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Cells, Cultured; Cholera Toxin; Colforsin; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Guanine Nucleotide Exchange Factors; Humans; Immunosuppressive Agents; Interleukin-5; Isoquinolines; Lymphocyte Activation; Phosphorylation; rap1 GTP-Binding Proteins; Rolipram; Sulfonamides; T-Lymphocytes | 2001 |
Diazepam increases the hypothalamic-pituitary-adrenocortical (HPA) axis activity by a cyclic AMP-dependent mechanism.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Animals; Corticosterone; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Diazepam; Flumazenil; Hypothalamus; Isoquinolines; Male; Phosphodiesterase Inhibitors; Pituitary Gland; Rats; Rats, Sprague-Dawley; Rolipram; Sulfonamides | 2001 |
Cyclic AMP-mediated modulation of epileptiform afterdischarge generation in rat hippocampal slices.
Topics: Action Potentials; Adenylyl Cyclases; Animals; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Electrophysiology; Enzyme Activators; Enzyme Inhibitors; Epilepsy; Hippocampus; Isoquinolines; Male; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Rolipram; Seizures; Sulfonamides; Thionucleotides | 2002 |
beta-Arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates beta-adrenoceptor switching from Gs to Gi.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Animals, Newborn; Arrestins; beta-Arrestins; Cell Line; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Enzyme Activation; Enzyme Inhibitors; Genes, Dominant; Green Fluorescent Proteins; Humans; Isoquinolines; Luminescent Proteins; Models, Biological; Myocardium; Pertussis Toxin; Phosphoric Diester Hydrolases; Phosphorylation; Rats; Receptors, Adrenergic, beta; Rolipram; Signal Transduction; Sulfonamides; Time Factors; Transfection | 2003 |
Phosphodiesterase 4 inhibition synergizes with relaxin signaling to promote decidualization of human endometrial stromal cells.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Decidua; Drug Synergism; Endometrium; Enzyme Inhibitors; Feedback, Physiological; Female; Gene Expression; Humans; Insulin-Like Growth Factor Binding Protein 1; Isoenzymes; Isoquinolines; Middle Aged; Prolactin; Relaxin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rolipram; Signal Transduction; Stromal Cells; Sulfonamides | 2004 |
Adenovirus-mediated delivery and expression of a cAMP-dependent protein kinase inhibitor gene to BEAS-2B epithelial cells abolishes the anti-inflammatory effects of rolipram, salbutamol, and prostaglandin E2: a comparison with H-89.
Topics: Activating Transcription Factor 1; Adaptor Proteins, Signal Transducing; Adenosine Monophosphate; Adenoviridae; Albuterol; Animals; Arachidonic Acid; Carrier Proteins; Cells, Cultured; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Dinoprostone; DNA-Binding Proteins; Drug Interactions; Epithelial Cells; Gene Expression Regulation; Gene Transfer Techniques; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Intracellular Signaling Peptides and Proteins; Isoquinolines; Phosphorylation; Rabbits; Rolipram; Sulfonamides; Transcription Factors; Tritium | 2004 |
Inhibitory effects of group II mGluR-related drugs on memory performance in mice.
Topics: Amino Acids; Animals; Anticonvulsants; Avoidance Learning; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclopropanes; Dose-Response Relationship, Drug; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Glycine; Isoquinolines; Male; Memory; Mice; Reaction Time; Receptors, Metabotropic Glutamate; Rolipram; Signal Transduction; Sulfonamides; Tetradecanoylphorbol Acetate; Xanthenes | 2004 |
Effect of phosphodiesterase 4 inhibitors on NFAT-dependent cyclooxygenase-2 expression in human T lymphocytes.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Carbazoles; Colforsin; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclooxygenase 2; DNA; DNA-Binding Proteins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Immunoblotting; Indoles; Isoquinolines; Jurkat Cells; Luciferases; Membrane Proteins; NFATC Transcription Factors; Nuclear Proteins; Plasmids; Promoter Regions, Genetic; Prostaglandin-Endoperoxide Synthases; Protein Binding; Pyrroles; RNA, Messenger; Rolipram; Sulfonamides; T-Lymphocytes; Transcription Factors; Transcriptional Activation; Transfection | 2004 |
Irsogladine, an anti-ulcer drug, suppresses superoxide production by inhibiting phosphodiesterase type 4 in human neutrophils.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Anti-Ulcer Agents; Bucladesine; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 1; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Gastric Mucosa; Humans; Isoenzymes; Isoquinolines; Neutrophils; Rolipram; Sulfonamides; Superoxides; Triazines | 2004 |
Cellular mechanisms underlying prostaglandin-induced transient cAMP signals near the plasma membrane of HEK-293 cells.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adaptor Proteins, Signal Transducing; Adenylyl Cyclases; Buffers; Cell Line; Cell Membrane; Computer Simulation; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 4; Humans; Ion Channel Gating; Ion Channels; Isoquinolines; Kinetics; Models, Biological; Nucleotides, Cyclic; Peptides; Phosphodiesterase Inhibitors; Prostaglandins; Protein Kinase Inhibitors; Rolipram; Signal Transduction; Sulfonamides | 2007 |
Prolonged heterologous beta2-adrenoceptor desensitization promotes proasthmatic airway smooth muscle function via PKA/ERK1/2-mediated phosphodiesterase-4 induction.
Topics: Adrenergic beta-2 Receptor Agonists; Animals; Asthma; Butadienes; Cells, Cultured; Colforsin; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 4; Dinoprostone; Enzyme Induction; Humans; Isoquinolines; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle Contraction; Muscle Relaxation; Nitriles; Pertussis Toxin; Phosphodiesterase 4 Inhibitors; Rabbits; Receptors, G-Protein-Coupled; Rolipram; Signal Transduction; Sulfonamides; Trachea | 2008 |
The role of the PDE4D cAMP phosphodiesterase in the regulation of glucagon-like peptide-1 release.
Topics: Animals; Cell Line; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Enteroendocrine Cells; Glucagon-Like Peptide 1; Glucose; Isoenzymes; Isoquinolines; Mice; Phosphodiesterase 3 Inhibitors; Protein Kinase Inhibitors; Rats; Rolipram; Sulfonamides | 2009 |
Glucagon-like peptide-1 protects mesenteric endothelium from injury during inflammation.
Topics: Animals; Capillary Permeability; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dideoxyadenosine; Endothelium, Vascular; Enzyme Inhibitors; Female; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Inflammation; Isoquinolines; Lipopolysaccharides; Mesentery; Peptide Fragments; Perfusion; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Glucagon; Rolipram; Sulfonamides; Venules | 2009 |
The ceramide-1-phosphate analogue PCERA-1 modulates tumour necrosis factor-alpha and interleukin-10 production in macrophages via the cAMP-PKA-CREB pathway in a GTP-dependent manner.
Topics: Adenylyl Cyclases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bucladesine; Calcium Signaling; Cell Line; Cell Membrane; Ceramides; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Dinoprostone; Enzyme Inhibitors; Genes, Reporter; Guanosine Triphosphate; Imidazoles; Indoles; Interleukin-10; Isoquinolines; Lipopolysaccharides; Macrophages; Mice; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Pyridines; Response Elements; Ribosomal Protein S6 Kinases, 90-kDa; Rolipram; Signal Transduction; Sulfonamides; Transfection; Tumor Necrosis Factor-alpha | 2010 |
Soluble adenylyl cyclase mediates bicarbonate-dependent corneal endothelial cell protection.
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Annexin A5; Apoptosis; Bicarbonates; Caspase 3; Cattle; Cells, Cultured; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Cytochromes c; Epithelium, Corneal; Estradiol; Isoquinolines; Phosphodiesterase 4 Inhibitors; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; RNA, Small Interfering; Rolipram; Staurosporine; Sulfonamides | 2011 |
Phosphodiesterase inhibitors control A172 human glioblastoma cell death through cAMP-mediated activation of protein kinase A and Epac1/Rap1 pathways.
Topics: 1-Methyl-3-isobutylxanthine; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Glioblastoma; Guanine Nucleotide Exchange Factors; Humans; Isoquinolines; Phosphodiesterase Inhibitors; Phosphorylation; Protein Kinase Inhibitors; Rolipram; Shelterin Complex; Signal Transduction; Sulfonamides; Telomere-Binding Proteins; Theophylline | 2012 |
Downregulation of phosphodiesterase 4B (PDE4B) activates protein kinase A and contributes to the progression of prostate cancer.
Topics: Cell Line, Tumor; Cell Proliferation; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 4; Disease Progression; Down-Regulation; Humans; Hydrogen Peroxide; Isoquinolines; Male; Phosphodiesterase 4 Inhibitors; Prostatic Neoplasms; Protein Kinase Inhibitors; Rolipram; Sulfonamides | 2012 |
Role of yessotoxin in calcium and cAMP-crosstalks in primary and K-562 human lymphocytes: the effect is mediated by anchor kinase A mitochondrial proteins.
Topics: A Kinase Anchor Proteins; Antineoplastic Agents; Calcium; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Cell Survival; Culture Media; Cyclic AMP; Cytosol; Enzyme Activation; Humans; Isoquinolines; K562 Cells; Lymphocytes; Mitochondria; Mitochondrial Proteins; Mollusk Venoms; Oxocins; Phosphodiesterase 4 Inhibitors; Rolipram; Sulfonamides; Thapsigargin | 2012 |
Phosphodiesterase inhibitor modulation of brain microvascular endothelial cell barrier properties.
Topics: Actins; Brain; Capillary Permeability; Carbazoles; Cells, Cultured; Cilostazol; Claudin-5; Dipyridamole; Drug Interactions; Electric Impedance; Endothelial Cells; Histamine; Humans; Isoquinolines; Phosphodiesterase Inhibitors; Protein Kinase Inhibitors; Pyrroles; Rolipram; Sulfonamides; Tetrazoles | 2012 |